IMCR vs RTX · rev $222.6M vs P/E 36, rev $46.78B
Immunocore Holdings Ltd (IMCR) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
IMCR currently screens at market cap $1.45B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the IMCR and RTX stock pages for the full models.
Not investment advice.